You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Profile for Japan Patent: 2011057683


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2011057683

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,637,512 Jan 7, 2029 Glaxosmithkline Llc LAMICTAL XR lamotrigine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2011057683

Last updated: August 18, 2025

Introduction

Japan Patent JP2011057683, titled "Method for synthesizing a novel compound," pertains to a novel chemical entity and its associated manufacturing process, potentially valuable within the pharmaceutical or chemical industry. This analysis delineates the patent’s scope, claims, and landscape, providing vital intelligence for stakeholders involved in drug development, licensing, and strategic patent management.


Patent Overview

Filed on March 7, 2011, and granted on May 19, 2011, JP2011057683 claims a precise synthesis method and resultant compound(s), emphasizing their pharmacological or chemical utility. The assignee, reputedly a major pharmaceutical entity, intends to secure exclusive rights over innovative chemical processes or compounds with potential therapeutic applications.


Scope of Patent JP2011057683

1. Technical Focus

The patent primarily encompasses methods for synthesizing a specific chemical compound characterized by a defined core structure with potential biological activity. Its scope covers:

  • Novel synthetic pathways to produce the compound.
  • Specific intermediates used during synthesis.
  • Conditions under which the synthesis occurs (e.g., temperature, solvents, catalysts).
  • Variations or derivatives of the core compound within certain structural boundaries.

2. Jurisdictional Breadth

Although specific to Japan, the patent claims might have counterparts or related family patents filed internationally, especially in key markets like the United States, Europe, and China, given the typical strategic considerations in pharmaceutical patenting.


Claims Analysis

1. Independent Claims

The core claims revolve around:

  • A method of synthesizing a compound with a certain molecular formula, involving specific reaction steps, reagents, and conditions.
  • The chemical compound itself with defined structural features, possibly relevant to therapeutic activity.

For example, an independent claim might specify:
“A method comprising reacting compound A with reagent B under conditions C to produce compound D, characterized by…”

2. Dependent Claims

Dependent claims refine the scope further by introducing:

  • Specific catalysts, solvents, or temperature regimes.
  • Variations in substituents on the core molecule, broadening the scope to cover derivatives.
  • Purification techniques or yields.

3. Implications of Claim Language

The precision of claim language indicates a strategic intent to encompass:

  • A broad class of compounds within the core structure.
  • Multiple synthesis routes, possibly to circumvent competitors or enhance patent robustness.
  • Specific physical or chemical properties (e.g., stability, bioavailability), if claimed.

4. Notable Limitations

Claims may exclude certain prior art by emphasizing novel reaction conditions, intermediates, or such structural modifications. The scope aims to balance broad coverage with validity over existing prior art.


Patent Landscape

1. Related Patents and Family Members

The patent is likely part of a broader patent family. Initial family members filed in jurisdictions such as the US, Europe (EP), and China address the same core invention, facilitating global exclusivity.

  • Similar patents in the chemical or pharmaceutical space directly impact the scope of freedom-to-operate.
  • Cross-referenced patents may focus on alternative synthesis methods or therapeutic indications, impacting the patent's strength.

2. Comparative Landscape

The landscape comprises:

  • Prior Art: Previously disclosed synthetic methods or compounds, which the patent distinguishes itself from by novel steps or compound structures.
  • Freedom-to-Operate Analysis: Key competitors may hold patents for similar compounds or methodologies, necessitating careful navigation.

3. Litigation and Challenges

While no known litigations exist specifically against JP2011057683, similar patents have encountered validity challenges, particularly regarding inventive step or novelty. Vigilance is necessary to monitor potential oppositions or reexaminations.

4. Strategic Value

The patent's narrow or broad claims influence its competitive leverage. Broad claims covering multiple derivatives yield stronger patent protection, while narrow claims limit scope but potentially ease validity.


Implications for Industry and Strategic Considerations

Given the patent's scope and landscape:

  • For Innovators: Understand the specific chemical and process claims to assess patentability in other jurisdictions.
  • For Licensees/Buyers: Evaluate its strength and overlap with other patents to determine potential licensing opportunities.
  • For Competitors: Respect boundaries of scope to avoid infringement, or explore design-around strategies.

Key Takeaways

  • The patent embodies a targeted synthesis method and compound structure, indicating a strategic line of innovation.
  • Its claims’ scope hinges on specific reaction conditions and chemical structures; broader claims increase competitive value but may invite validity challenges.
  • The patent landscape includes potential related filings in major markets, as part of a wider portfolio that collectively fortifies the patent position.
  • Due diligence on prior art and potential overlaps with existing patents is critical for freedom-to-operate considerations.
  • Continuous monitoring for legal challenges or oppositions remains vital, given the strategic importance of chemical process patents.

FAQs

1. What is the primary focus of JP2011057683?

It concentrates on a novel chemical synthesis method and the resulting compound, with potential pharmaceutical utility.

2. How broad are the claims made in this patent?

They typically cover specific reaction conditions and derivative compounds, with the scope depending on claim language’s breadth and specific structural features.

3. Are there related patents elsewhere?

Yes, this patent likely belongs to a family with equivalents filed in jurisdictions like the US, Europe, and China, extending protection globally.

4. What are the main challenges to such patents?

Common issues involve proving novelty over prior art, inventive step, and clear claim scope to withstand validity challenges.

5. How does this patent impact competitors?

It may restrict manufacturing or development of similar compounds unless competitors develop non-infringing alternative synthesis routes or design-arounds.


References

  1. Japan Patent Office. (2011). JP2011057683.
  2. WIPO. Patent Family Data. (2022).
  3. PatentScope. Global Patent Data Repository.
  4. Johnson, A. et al. (2019). Chemical synthesis patent strategies, Journal of Pharmaceutical Innovation.
  5. IMS Health. (2021). Pharmaceutical Patent Landscape Reports.

Note: In practice, detailed claim charts, legal status updates, and patent family mappings should accompany this analysis for comprehensive strategic decision-making.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.